Valiant Laboratories Ltd

Valiant Laboratories Ltd

Valiant Laboratories Ltd has announced the re-appointment of its Managing Director, Mr. Santosh Vora, and Independent Director, Mrs. Sonal Vira, for a further period of five years, subject to shareholder approval. The company has also approved the continuation of directorship of Mr. Shantilal Vora as a Non-Executive Non-Independent Director. Additionally, the company has approved the opening of a new corporate office and the shifting of its registered office to a new location.

Valiant Laboratories Ltd

Valiant Laboratories Ltd has announced its audited standalone and consolidated financial results for the quarter ended June 30, 2026, with the Board of Directors taking note of the audit report issued by Raman S. Shah & Co. The results are in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Valiant Laboratories Ltd

Valiant Laboratories Ltd has announced its audited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's board of directors has considered and approved the results, and the statutory auditor has issued a report. The results are presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and give a true and fair view of the company's net profit/loss and other comprehensive income.

Valiant Laboratories Ltd

Valiant Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve financial results for the quarter ended June 30, 2026.